(Q41200136)

English

Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia

scientific article published on 12 February 2015

Statements

Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia (English)
Christie M Ballantyne
Joel Neutel
Anne Cropp
William Duggan
Ellen Q Wang
David Plowchalk
Kevin Sweeney
Nitin Kaila
John Vincent
Harold Bays
12 February 2015
1212-1221

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit